Jie Jiang

发表

Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression

W. Liu, Chun Yan, Li Li, 2021, Translational cancer research.

Two new spirooxindole alkaloids from rhizosphere strain Streptomyces sp. xzqh-9.

Xianming Deng, Si-Yang Song, Tingting Fang, 2014, Bioorganic & medicinal chemistry letters.

Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.

Xianming Deng, Ting Zhang, Si-Yang Song, 2017, Cancer research.

A new ALK inhibitor overcomes resistance to first and secondgeneration inhibitors in NSCLC

Zheng Wang, Qiyuan Li, Yan Liu, 2021 .

A non‐covalent inhibitor XMU‐MP‐3 overrides ibrutinib‐resistant BtkC481S mutation in B‐cell malignancies

Xianming Deng, Si-Yang Song, C. Yun, 2019, British journal of pharmacology.

Exosome‐derived miR‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB

J. Ran, Zongqiang Hu, Wang Li, 2023, Environmental toxicology.

Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression.

Zongqiang Hu, Yan-feng Yin, Jie Jiang, 2021, Journal of gastrointestinal oncology.

Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3

J. Ran, Yun Dong, Zongqiang Hu, 2023, Molecular Biology Reports.

Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

Gang Chen, J. Ran, Zongqiang Hu, 2023, Molecular Cancer.

Immunological characteristics of human umbilical cord mesenchymal stem cells after hepatogenic differentiation.

Li Ma, Shiming Feng, Zongqiang Hu, 2022, Bio-medical materials and engineering.

A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC

Zheng Wang, Qiyuan Li, Yan Liu, 2021, EMBO molecular medicine.